Home > Insider Trading > Filing (0001140361-18-031059)

Filing Details

Accession Number:: 0001140361-18-031059
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-02 21:05:35
Reporting Period:: 2018-07-02

Accepted Time:: 2018-07-02 21:05:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595585	Tricida Inc.	TCDA	Pharmaceutical Preparations (2834)	463372526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744280	I Sandra Coufal	7000 Shoreline Court Suite 201 South San Francisco CA 94080		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-02	169,936	$0.00	245,312	No	4	C	Indirect	By Sibling Co-Investment LLC
Common Stock	Acquisiton	2018-07-02	893,292	$0.00	893,292	No	4	C	Indirect	By Sibling Capital Fund II-A L.P.
Common Stock	Acquisiton	2018-07-02	3,139,600	$0.00	3,139,600	No	4	C	Indirect	By Sibling Capital Fund II-B L.P.
Common Stock	Acquisiton	2018-07-02	1,810,195	$0.00	1,810,195	No	4	C	Indirect	By Sibling Capital Fund II-C L.P.
Common Stock	Acquisiton	2018-07-02	599,379	$0.00	599,379	No	4	C	Indirect	By Sibling Capital Fund II-D L.P.
Common Stock	Acquisiton	2018-07-02	463,158	$19.00	463,158	No	4	P	Indirect	By Sibling Insiders Fund II L.P.
Common Stock	Acquisiton	2018-07-02	3,632	$0.00	217,199	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Sibling Co-Investment LLC
No	4	C	Indirect	By Sibling Capital Fund II-A L.P.
No	4	C	Indirect	By Sibling Capital Fund II-B L.P.
No	4	C	Indirect	By Sibling Capital Fund II-C L.P.
No	4	C	Indirect	By Sibling Capital Fund II-D L.P.
No	4	P	Indirect	By Sibling Insiders Fund II L.P.
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2018-07-02	676,349	$0.00	169,936	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2018-07-02	3,555,304	$0.00	893,292	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-07-02	12,495,612	$0.00	3,139,600	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2018-07-02	7,204,578	$0.00	1,810,195	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2018-07-02	2,385,532	$0.00	599,379	$0.00
Common Stock	Stock Option (right to buy)	Acquisiton	2018-07-02	13,147	$0.00	13,147	$19.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
13,147	2028-06-27	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,125	Indirect	By Coufal Irrevocable Trust

Footnotes

Each of the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date. Each of the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock.
The shares are held directly by Sibling Co-Investment LLC ("Sibling Co-Investment"). Sibling Capital Ventures LLC ("SCV") is the sole manager of Sibling Co-Investment.
The shares are held directly by Sibling Capital Fund II-A L.P. ("Sibling A"). SCV is the sole general partner of Sibling A.
The shares are held directly by Sibling Capital Fund II-B L.P. ("Sibling B"). Sibling Capital Ventures II LLC ("SCV II") is the sole general partner of Sibling B.
The shares are held directly by Sibling Capital Fund II-C L.P. ("Sibling C"). Sibling Capital Ventures III LLC ("SCV III") is the sole general partner of Sibling C.
The shares are held directly by Sibling Capital Fund II-D L.P. ("Sibling D"). Sibling Capital Ventures IV LLC ("SCV IV") is the sole general partner of Sibling D.
The shares are held directly by Sibling Insiders Fund II L.P. ("Insiders Fund", and together with Sibling A, Sibling B, Sibling C and Sibling D, the "Sibling Funds"). Sibling Insiders II LLC ("Insiders II") is the sole general partner of Insiders Fund.
The Reporting Person is co-manager of SCV, SCV II, SCV III, SCV IV and Insiders II and, as such, may be deemed to have voting and investment power with respect to the shares held by Sibling Co-Investment and the Sibling Funds. The Reporting Person disclaims beneficial ownership of shares held by Sibling Co-Investment and the Sibling Funds, except to the extent of her proportionate pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Represents restricted stock units ("RSUs") that, subject to the Issuer's initial public offering ("IPO") closing on or before July 16, 2018, vest on the earlier of (i) the one-year anniversary of June 27, 2018 (the "Grant Date") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the "Next Annual Meeting"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock.
The spouse of the Reporting Person is the sole trustee of the Coufal Irrevocable Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Coufal Irrevocable Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, and subject to the Issuer's IPO closing on or before July 16, 2018, this option vests ratably on a monthly basis, on the monthly anniversary of June 27, 2018 ("Option Date"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date ("Vesting Date"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting.